Warning: mkdir(): Permission denied in /data/Websites/newwiki-mpm/fuel/core/classes/log.php on line 122

Warning!

ErrorException [ Warning ]: mkdir(): Permission denied

COREPATH/classes/log.php @ line 122:

121:	
122:	mkdir($filepath, \Config::get('file.chmod.folders', 0777), true);
123:	umask($old);
EGFR - Wiki-MPM

Search Results for: EGFR

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel HEBP1 heme binding protein 1
  • G alpha (i) signalling events
  • Formyl peptide receptors bind formyl peptides and many other ligands
Novel PHKG1 phosphorylase kinase catalytic subunit gamma 1
  • Glycogen breakdown (glycogenolysis)
  • Glycogen breakdown (glycogenolysis)
  • Fostamatinib
Novel POM121L12 POM121 transmembrane nucleoporin like 12
Novel STAG3L4 stromal antigen 3-like 4 (pseudogene)
ABL2 ABL proto-oncogene 2, non-receptor tyrosine kinase
  • Role of ABL in ROBO-SLIT signaling
  • Role of ABL in ROBO-SLIT signaling
  • Negative regulation of FLT3
  • ATP
  • Dasatinib
  • XL228
  • K-00546
  • Fostamatinib
ACTA1 actin alpha 1, skeletal muscle
  • Striated Muscle Contraction
  • Latrunculin A
  • Sucrose
  • Ulapualide A
  • Kabiramide C
  • Jaspisamide A
  • Tmr
  • 1-Methylhistidine
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Aplyronine A
  • Reidispongiolide A
  • Reidispongiolide C
  • Sphinxolide B
  • Latrunculin B
  • Congenital fiber type disproportion (CFTD)
  • Cap myopathy
  • Nemaline myopathy
ADRM1 adhesion regulating molecule 1
  • UCH proteinases
  • Ub-specific processing proteases
AGTR1 angiotensin II receptor type 1
  • Peptide ligand-binding receptors
  • G alpha (q) signalling events
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Valsartan
  • Olmesartan
  • Losartan
  • Candesartan cilexetil
  • Eprosartan
  • Telmisartan
  • Irbesartan
  • Forasartan
  • Saprisartan
  • Tasosartan
  • CYT006-AngQb
  • Azilsartan medoxomil
  • Fimasartan
  • Angiotensin II
  • Candesartan
  • Renal tubular dysgenesis
AHNAK AHNAK nucleoprotein
AHSA1 activator of HSP90 ATPase activity 1
AIP aryl hydrocarbon receptor interacting protein
  • Aryl hydrocarbon receptor signalling
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
AKAP12 A-kinase anchoring protein 12
ALCAM activated leukocyte cell adhesion molecule
  • L1CAM interactions
ALDOA aldolase, fructose-bisphosphate A
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Artenimol
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
AMH anti-Mullerian hormone
  • Signaling by BMP
  • Transcriptional regulation of testis differentiation
  • 46,XY disorders of sex development (Other), including: Persistent Mullerian duct syndrome; Hypospadias; Cryptorchidism
ANKS1A ankyrin repeat and sterile alpha motif domain containing 1A
ANKS1B ankyrin repeat and sterile alpha motif domain containing 1B
ANXA1 annexin A1
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Smooth Muscle Contraction
  • Interleukin-4 and Interleukin-13 signaling
  • Amcinonide
  • Fluocinolone acetonide
  • Hydrocortisone
  • Methylprednisolone
  • Clobetasol propionate
  • Budesonide
  • Dexamethasone
  • Hydrocortisone aceponate
  • Hydrocortisone acetate
  • Hydrocortisone butyrate
  • Hydrocortisone cypionate
  • Hydrocortisone phosphate
  • Hydrocortisone probutate
  • Hydrocortisone valerate
  • Prednisolone phosphate
  • Dexamethasone acetate
  • Betamethasone phosphate
AOPEP aminopeptidase O (putative)
  • Metabolism of Angiotensinogen to Angiotensins
AP2B1 adaptor related protein complex 2 subunit beta 1
  • Nef Mediated CD4 Down-regulation
  • Retrograde neurotrophin signalling
  • Retrograde neurotrophin signalling
  • Nef Mediated CD8 Down-regulation
  • MHC class II antigen presentation
  • EPH-ephrin mediated repulsion of cells
  • Recycling pathway of L1
  • Recycling pathway of L1
  • WNT5A-dependent internalization of FZD4
  • WNT5A-dependent internalization of FZD2, FZD5 and ROR2
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • VLDLR internalisation and degradation
  • LDL clearance
  • Potential therapeutics for SARS

Page 1 out of 21 pages